Trash doesn't give a about any other single human being, so Ks, 10Ks, 100Ks diseased or dead doesn't bother him in the least
All he wants is an economic recovery so he can brag about being victorious wartime President who deserves to be, who must be reelected.
Two-Thirds of Severe COVID-19 Cases Improved on Experimental Drug
Sciences Inc.’s experimental drug for patients with severe COVID-19 infections showed promise in an early analysis, raising tentative hope that the first treatment for the novel virus may be on the horizon.
The report published in the New England Journal of Medicine tracked 53 people in the U.S., Europe and Canada who needed respiratory support, with about half receiving mechanical ventilation and four on a heart-lung by-pass machine. Eight additional patients were left out of the analysis: one due to a dosing error and seven because no information was available on how they fared.
All received remdesivir for up to 10 days on a compassionate use basis, a program that allows people to use unapproved medicines when no other treatment options are available. Over 18 days, 68% of the patients improved, with 17 of the 30 patients on mechanical ventilation being able to get off the breathing device. Almost half of the patients studied were ultimately discharged, while 13% died. Mortality was highest among those who were on a ventilator, with 18% of them dying.
“We cannot draw definitive conclusions from these data, but the observations from this group of hospitalized patients who received remdesivir are hopeful,” said lead author Jonathan Grein, director of hospital epidemiology at Cedars-Sinai Medical Center in Los Angeles, in a statement from Gilead. The Foster City, California-based company provided the medication and also helped analyze the results.
Some scientists have expressed skepticism with regard to the results.
“The data from this paper are almost uninterpretable,” Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine, said in an emailed statement. “There is some evidence suggesting efficacy, but we simply do not know what would have happened to these patients had they not been given the drug.”
Several large scale clinical trials are underway to evaluate the benefit of remdesivir for COVID-19, the disease caused by the novel coronavirus that has infected more than 1.65 million people worldwide and killed 100,000. One that was conducted in China could report results this month. Another, sponsored by the U.S. National Ins utes of Health, has enrolled patients rapidly as the virus spread throughout the U.S. It could also report results in the coming weeks. Gilead itself is sponsoring an additional two trials.
‘Answers Are Needed’
“In studying remdesivir, the question is not just whether it is safe and effective against COVID-19, but in which patients it shows activity, how long should they receive treatment and at what stage of their disease would treatment be most beneficial,” said Daniel O’Day, Gilead’s chairman and chief executive officer. “Many answers are needed, which is why we need multiple types of studies involving many types of patients.”
Some of these answers will emerge in the coming weeks with the release of initial data from the various clinical trials, O’Day said Friday in an open letter sent via email.
There are currently no treatments proven to work specifically against the coronavirus infection. Gilead has provided the medicine to more than 1,800 patients on a compassionate use basis.
Cheap to Make
If it’s shown to be safe and effective for treating COVID-19, the medication is estimated to cost about $9 a treatment to make, said Andrew Hill, a senior visiting research fellow in the pharmacology department at Liverpool University, and colleagues in a study Friday.
As an intravenous infusion, there would be additional costs to administer remdesivir, which are likely to exceed the estimated manufacturing, the authors said.
Results of controlled studies of remdesivir are highly anticipated because they will be some of the first rigorous large-scale studies completed on potential anti-coronavirus drugs.
President Donald Trump and others have touted the potential of hydroxychloroquine, an old malaria and lupus drug, for treating COVID-19. But that drug hasn’t yet been carefully studied in a large trial to see if it prevents severe complications. Most of the excitement stems from relentless social media promotion of a tiny French study whose methodology has been heavily criticized by many U.S. medical experts.
Remdesivir, a broad-spectrum antiviral, is viewed by researchers and doctors as one of the most promising agents against COVID-19 to enter human trials to date. In lab studies conducted prior to the COVID-19 outbreak on numerous compounds, researchers at the University of North Carolina and Vanderbilt University found the drug had potent activity against against a wide variety of coronaviruses similar to the new coronavirus.
Tested for Ebola
Because it had already been tested in patients with Ebola, where it was shown to be safe but ineffective, researchers were able to quickly begin studying it human trials when the COVID-19 pandemic hit.
About one in four patients on the medicine experienced severe side effects, including multiple-organ dysfunction syndrome, septic shock, acute kidney injury and low blood pressure. Another 23% showed signs of liver damage on laboratory tests. Four patients had to stop receiving infusions of the drug entirely.
Remdesivir was considered to be the most promising therapeutic candidate based on its broad antiviral spectrum, and existing data based on human and animal studies, a World Health Organization panel said in January. The medication was developed initially for Ebola and studied in patients in Eastern Congo.
If it works well, one issue will be whether there is enough of a supply of the drug, especially if the epidemic is still raging. Gilead has been working all-out to bolster supply of the hard-to-make medicine. It said earlier this month that it hopes to to have 500,000 treatment courses by October, and more than 1 million by year-end. Production time has also been accelerated to six months from one year.
COVID-19 Reaches U.S. Slaughterhouses
Meat giant JBS USA Holdings closed its Souderton, Pennsylvania slaughter operation.
Tyson Foods closed its Columbus Junction, Iowa pork slaughterhouse.
Pennsylvania-based Empire Kosher Poultry temporarily closed its doors and
Sanderson Farms asked employees at its Moultrie, GA slaughter operation to stay home.
COVID-19 has hit U.S. slaughterhouses big time.
In addition to management-ruled closures,
employees have also walked out
because of the growing number of COVID-19 infected employees and the risks on site.
https://www.counterpunch.org/2020/04/10/covid-19-reaches-u-s-slaughterhouses/
Everybody back to work 1 May, Trash's catastrophic Reign of Crap to continue.
Last edited by boutons_deux; 04-11-2020 at 03:19 PM.
Lots of people think they got the virus Jan and feb
No one died
They had symptoms of it
17 causes reported in Yuma country 3 only activate
^TL;DR for ducks wall of text: A couple of people improved after taking this, but we're not sure why and we can't actually use it on most people
Keep pushing those drugs, moron.
Last edited by TimDunkem; 04-11-2020 at 02:55 PM.
Just "thinking" you have Covid is as good as a test, and 10 people taking a drug and surviving is as good as a cure in ducks world.
ducks said it long ago
now he gets his kool-aid through an IV
According to Bill De Blasio.
Cuomo slapped him over it. Says he doesn’t have the authority to open or close anything.
Dont know who has the power to do what over the other but this beef is hilarious to me.
Delta Reportedly Tells Flight Attendants Not to Notify Colleagues If They Get Coronavirus
Delta Air Lines has sent instructions to over 25,000 flight attendants saying that in the event they are diagnosed with the novel coronavirus,
they should “refrain from notifying” other employees at the company or publicly disclosing their condition online,
Dozens of the company’s pilots have been confirmed diagnosed with the virus and
many employees suspected Delta was trying to prevent information about pilots who tested positive from getting to flight crews,
https://gizmodo.com/delta-reportedly-tells-flight-attendants-not-to-notify-1842799488?utm_source=gizmodo_newsletter&utm_mediu m=email&utm_campaign=2020-04-11
But dozens of interviews with current and former officials and a review of emails and other records revealed many previously unreported details and a fuller picture of the roots and extent of his halting response as the deadly virus spread:
The National Security Council office responsible for tracking pandemics received intelligence reports in early January predicting the spread of the virus to the United States, and within weeks was raising options like keeping Americans home from work and shutting down cities the size of Chicago. Mr. Trump would avoid such steps until March.
Despite Mr. Trump’s denial weeks later, he was told at the time about a Jan. 29 memo produced by his trade adviser, Peter Navarro, laying out in striking detail the potential risks of a coronavirus pandemic: as many as half a million deaths and trillions of dollars in economic losses.
The health and human services secretary, Alex M. Azar II, directly warned Mr. Trump of the possibility of a pandemic during a call on Jan. 30, the second warning he delivered to the president about the virus in two weeks. The president, who was on Air Force One while traveling for appearances in the Midwest, responded that Mr. Azar was being alarmist.
Mr. Azar publicly announced in February that the government was establishing a “surveillance” system in five American cities to measure the spread of the virus and enable experts to project the next hot spots. It was delayed for weeks. The slow start of that plan, on top of the well-do ented failures to develop the nation’s testing capacity, left administration officials with almost no insight into how rapidly the virus was spreading. “We were flying the plane with no instruments,” one official said.
By the third week in February, the administration’s top public health experts concluded they should recommend to Mr. Trump a new approach that would include warning the American people of the risks and urging steps like social distancing and staying home from work. But the White House focused instead on messaging and crucial additional weeks went by before their views were reluctantly accepted by the president — time when the virus spread largely unimpeded.
https://apple.news/A4fMB0P14RL2seyOYjG-xCQ
Trump pushed to shutter pandemic monitoring program even as he received reports of COVID-19
Trump’s administration pushed ahead with its plan to shutter a major agency tasked with identifying new sources of potential pandemics,
even as the first reports of the novel coronavirus appeared in China —
then frantically tried to reverse the decision as the crisis worsened.
“As early indications of China’s coronavirus outbreak emerged in late December,
the Trump administration notified Congress it would still follow through with its plan to shutter a US Agency for International Development surveillance program
tasked with detecting new, potentially dangerous infectious diseases and helping foreign labs stop emerging pandemic threats around the world,”
https://www.rawstory.com/2020/04/tru...vid-19-report/
Heckuva job, Donnie.
How much can Donnie up between now 20 Jan 2121?
It will certainly be a lot ups
Same way you grow weed
Now you want small scale anecdotes instead of a comprehensive study lol
Chris has issues with any governor trying to stop to the spread of corona
A PHLEBOTOMIST?!? Is that seriously this person’s only credential? I looked at the article and didn’t see anything else. Freaking amazing.
And hopefully the person who quoted and published her too
What are the lives of mere employees compared to the glory and continued profitability of an international airline?
"the number of patients coming through the testing center who appear to have already had coronavirus and gotten over it
is far greater than those who currently have the disease."
that's not news, it's expected.
so ing what?
I imagine this is happening at a lot of the businesses that are open right now.
these last couple of pages
I want proof of your claim from you.
Officers have been overreaching all over the country.
There are currently 7 users browsing this thread. (0 members and 7 guests)
Posting Permissions
Reply With Quote
